Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH)

Gonadotrophin releasing hormone analogues (GnRHa) have been used to treat recurrent endometrial cancer. However, the mode of action is uncertain. Our previous studies showed no direct effect of GnRHa on endometrial cancer cell growth in vitro. We have now examined the effect of luteinizing hormone (...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, S, Bax, C M R, Chatzaki, E, Chard, T, Iles, R K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363464/
https://www.ncbi.nlm.nih.gov/pubmed/11104573
http://dx.doi.org/10.1054/bjoc.2000.1507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363464/
https://www.ncbi.nlm.nih.gov/pubmed/11104573
http://dx.doi.org/10.1054/bjoc.2000.1507

Ejemplares similares